Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
chlophedianol + pyrilamine
- Development stage
- Unknown
- Lead developer
- GM Pharmaceuticals
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
TexaClear Allergy Relief is an approved over-the-counter (OTC) fixed-dose combination drug developed and marketed by GM Pharmaceuticals. It contains chlophedianol hydrochloride, a centrally acting non-opioid cough suppressant, and pyrilamine maleate, a first-generation antihistamine. The drug is indicated for the temporary relief of mild to severe allergy symptoms, including sneezing, runny nose, watery eyes, itchy nose and throat, and allergy cough due to the common cold, hay fever, or other upper respiratory allergies. It is available in both liquid and tablet forms and is formulated to be free from dyes, alcohol, gluten, sugar, and acetaminophen.
- Brand names
- NinjacofTexaClear Allergy ReliefTexaClear Allergy Relief LiquidTexaClear Fast-Acting Allergy Relief TabletsTexaClear Kids Allergy + Cough ReliefTexaClear Kids Allergy ReliefVanacof CP
- Other names
- chlophedianol and pyrilaminechlophedianol hydrochloride and pyrilamine maleatechlophedianol/pyrilamine
02
Targets
HRH1 (Histamine H1 Receptor)
Beyond the preview
Go deeper on chlophedianol + pyrilamine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on chlophedianol + pyrilamine.